Astrocytes: The Stars in Neurodegeneration?
Today, neurodegenerative disorders like Alzheimer’s disease (AD), Parkinson’s disease (PD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) affect millions of people worldwide, and as the average human lifespan increases, similarly grows the number of patients. For many decades...
Main Authors: | Katarina Stoklund Dittlau, Kristine Freude |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/14/3/289 |
Similar Items
-
Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons
by: Y. X. Li, et al.
Published: (2018-09-01) -
The Many Faces of Astrocytes in Alzheimer's Disease
by: Michael D. Monterey, et al.
Published: (2021-08-01) -
Beta-Secretase 1 Underlies Reactive Astrocytes and Endothelial Disruption in Neurodegeneration
by: María Victoria Chacón-Quintero, et al.
Published: (2021-05-01) -
Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective
by: Patrycja Mulica, et al.
Published: (2021-05-01) -
Mature iPSC-derived astrocytes of an ALS/FTD patient carrying the TDP43A90V mutation display a mild reactive state and release polyP toxic to motoneurons
by: Fabiola Rojas, et al.
Published: (2023-07-01)